Solesence, Inc. - Common stock (SLSN)
Basic Materials › Perfumes, Cosmetics & Other Toilet Preparations
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 72% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 26.5% — good return on equity
- Revenue growing at 19% annually
Solesence, Inc. - Common stock (SLSN) is a Basic Materials company operating in Perfumes, Cosmetics & Other Toilet Preparations, listed on the NASDAQ , with a market capitalisation of $74 million . Key value metrics: P/E ratio 15.9, P/B ratio 4.21, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Solesence, Inc. - Common stock — Fundamental Analysis Summary
Solesence, Inc. - Common stock (SLSN) is currently trading 72% above its Graham Number of $0.61, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 15.9x.
On financial health, SLSN shows a moderate Piotroski F-Score of 4/9, and strong return on equity of 26.5% (sector average: -1.2%), and minimal leverage with a debt-to-equity ratio of 0.06.
StockPik's composite Value Score for SLSN is 82/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
SLSN reports a moderate gross margin of 28.2% (sector average: 12.8%) and a modest operating margin of 6.9%.
SLSN shows revenue growing at 19% year-over-year, with earnings declining at 58%.